health smarts. FDA Cautions About Stem Cell Claims

March 2012
PN;Mar2012, Vol. 66 Issue 3, p20
Trade Publication
The article reports that the U.S. Food and Drug Administration (FDA) has cautioned about stem cell claims. As stated, FDA has cautioned consumers to make sure any stem cell treatment they are considering has been approved by FDA or is being studied under a clinical investigation that has been submitted to FDA. It states that consumers should be aware that there are no approved stem cell products at present, other than cord blood.


Related Articles

  • What you may not know about UDI and were afraid to ask. Conway, Karen // Healthcare Purchasing News;Nov2012, Vol. 36 Issue 11, p70 

    The article reports on topics which were discussed at the 2012 Unique Device Identification Conference, which was held in September in Orlando, Florida. Topics included a unique device identification rule from the U.S. Food and Drug Administration (FDA), direct part marketing and the types of...

  • NEJM editorial calls for FDA to be given premarket approval authority. HS // Functional Ingredients;Mar2012, Issue 117, p14 

    The article reports on an editorial which was written by Massachusetts physician Pieter Cohen and appeared in an issue of the "New England Journal of Medicine". In his editorial Cohen called for stricter regulation on the subject of New Dietary Ingredients (NDI) and premarket approval for new...

  • The perils of dietary supplements. Lipman, Marvin M. // Consumer Reports on Health;Jun2012, Vol. 24 Issue 6, p11 

    No abstract available.

  • NDIs: THE RHINO IN THE ROOM. Schultz, Hank // Functional Ingredients;Apr2011, Issue 107, p24 

    The article reports on concerns which have been seen in the dietary and nutritional supplement industry concerning expected U.S. Food and Drug Administration (FDA) guidelines on New Dietary Ingredients, or ingredients which have come into the global market after October 15, 1994. A discussion of...

  • Culture of Quality. Coy, Casey // Functional Ingredients;Nov2012, Issue 124, p26 

    The article reports on increasing scrutiny which the U.S. dietary supplement industry is facing in 2012 from the U.S. Food and Drug Administration regarding violations of CFR111 Good Manufacturing Practices. A discussion of a Dietary Supplement Quality training program which was developed in...

  • Regulatory wrap-up.  // Functional Ingredients;Nov2012, Issue 124, p36 

    The article reports on regulations, including guidance on New Dietary Ingredients from the U.S. Food and Drug Administration, regulations on health claims from the Federal Trade Commission and regulations on Good Manufacturing Practices, which are impacting the dietary and food supplement...

  • Rollout of federal track-and-trace requirements begins soon. Traynor, Kate // American Journal of Health-System Pharmacy;12/1/2014, Vol. 71 Issue 23, p2006 

    The article reports that the phased-in implementation of U.S. Food and Drug Administration's tracking and pedigree regulations for medications will start January 1, 2015 requiring drug manufacturers and distributors to provide pharmacies with specific transaction information. Topics discussed...

  • FDA wins right to regulate therapies from patient's own processed cells.  // Transplant News;Aug2012, Vol. 22 Issue 8, p5 

    The article reports that the FDA has received the right to regulate therapies made from a patient's own processed stem cells. The ruling approved the FDA's claim that the stem cells collected for the therapy are altered in such a way that FDA must regulate cells as a drug. The FDA had brought an...

  • Dangerous devices.  // Consumer Reports;May2012, Vol. 77 Issue 5, p24 

    The article looks at safety concerns around the lack of testing of implanted medical devices. Topics discussed include the U.S. Food and Drug Administration (FDA) allowing untested devices to be sold after the manufacturer pays a small fee to file paperwork, a panel from the Institute of...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics